<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Incidence of positive peritoneal cytology in patients with endometrial carcinoma after hysteroscopy vs. dilatation and curettage</dc:title><dc:creator>Dovnik,	Andraž	(Avtor)
	</dc:creator><dc:creator>Crnobrnja,	Bojana	(Avtor)
	</dc:creator><dc:creator>Žegura Andrić,	Branka	(Avtor)
	</dc:creator><dc:creator>Takač,	Iztok	(Avtor)
	</dc:creator><dc:creator>Pakiž,	Maja	(Avtor)
	</dc:creator><dc:subject>endometrial carcinoma</dc:subject><dc:subject>peritoneal cytology</dc:subject><dc:subject>FIGO staging</dc:subject><dc:subject>hysteroscopy</dc:subject><dc:subject>dilatation and curettage</dc:subject><dc:description>Background: The aim of the study was to compare the frequency of positive peritoneal washings in endometrial cancer patients after either hysteroscopy (HSC) or dilatation and curettage (D&amp;C).

Patients and methods: We performed a retrospective analysis of 227 patients who underwent either HSC (N = 144) or D&amp;C (N = 83) and were diagnosed with endometrial carcinoma at the University Medical Centre Maribor between January 2008 and December 2014. The incidence of positive peritoneal cytology was evaluated in each group.

Results: There was no overall difference in the incidence of positive peritoneal washings after HSC or D&amp;C (HSC = 13.2%; D&amp;C = 12.0%; p = 0.803). However, a detailed analysis of stage I disease revealed significantly higher rates of positive peritoneal washings in the HSC group (HSC = 12.8%; D&amp;C = 3.4%; p = 0.046). Among these patients, there was no difference between both groups considering histologic type (chi-square = 0.059; p = 0.807), tumour differentiation (chi-square = 3.709; p = 0.156), the time between diagnosis and operation (t = 0.930; p = 0.357), and myometrial invasion (chi-square = 5.073; p = 0.079).

Conclusions: Although the diagnostic procedure did not influence the overall incidence of positive peritoneal washings, HSC was associated with a significantly higher rate of positive peritoneal cytology in stage I endometrial carcinoma compared to D&amp;C.</dc:description><dc:date>2017</dc:date><dc:date>2017-05-10 11:01:10</dc:date><dc:type>Znanstveno delo</dc:type><dc:identifier>65611</dc:identifier><dc:identifier>ISSN: 1581-3207</dc:identifier><dc:identifier>UDK: 618.14-006</dc:identifier><dc:identifier>OceCobissID: 784507</dc:identifier><dc:identifier>COBISS_ID: 5784127</dc:identifier><dc:identifier>DOI: 10.1515/raon-2016-0035</dc:identifier><dc:identifier>ISSN pri članku: 1581-3207</dc:identifier><dc:identifier>NUK URN: URN:SI:UM:DK:5AHINICP</dc:identifier><dc:language>sl</dc:language></metadata>
